424 related articles for article (PubMed ID: 19360713)
1. Downstream processing of value-added proteins in biotechnology: An Indian scenario.
Babu AK; Vijayalakshmi MA
Biotechnol J; 2009 Aug; 4(8):1132-9. PubMed ID: 19360713
[No Abstract] [Full Text] [Related]
2. Peptides: isolation, production, and use in India.
Nagaraj R
Biotechnol J; 2009 Mar; 4(3):329-34. PubMed ID: 19156729
[No Abstract] [Full Text] [Related]
3. Editorial: between molecular and macroscopic protein engineering.
Jungbauer A
Biotechnol J; 2008 Feb; 3(2):143. PubMed ID: 18283675
[No Abstract] [Full Text] [Related]
4. Patent protection for protein structure analysis.
Shimbo I; Nakajima R; Yokoyama S; Sumikura K
Nat Biotechnol; 2004 Jan; 22(1):109-12. PubMed ID: 14704710
[TBL] [Abstract][Full Text] [Related]
5. Rational and "irrational" design of proteins and their use in biotechnology.
Nixon AE; Firestine SM
IUBMB Life; 2000 Mar; 49(3):181-7. PubMed ID: 10868908
[TBL] [Abstract][Full Text] [Related]
6. Profiles of four top biotech companies in India.
Suresh N; Rao ChS
Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
[No Abstract] [Full Text] [Related]
7. Patent threat in emerging economies shifts to biotech.
Jayaranam K
Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
[No Abstract] [Full Text] [Related]
8. How will biotechnology fare in pharma's big plan?
Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
[No Abstract] [Full Text] [Related]
9. Rational optimization of proteins as drugs: a new era of 'medicinal biology'.
Szymkowski DE
Drug Discov Today; 2004 May; 9(9):381-3. PubMed ID: 15081952
[No Abstract] [Full Text] [Related]
10. Therapeutic antibodies: magic bullets hit the target.
Gura T
Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
[No Abstract] [Full Text] [Related]
11. An overview and historical perspective of protein biotechnology.
Udenfriend S
Bioprocess Technol; 1990; 7():1-8. PubMed ID: 1366818
[No Abstract] [Full Text] [Related]
12. The end of the beginning for genomic medicine.
Bailey D; Zanders E; Dean P
Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
[No Abstract] [Full Text] [Related]
13. Reinventing an industry.
Mandavilli A
Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
[No Abstract] [Full Text] [Related]
14. Developing diagnostics.
Lab Chip; 2007 Feb; 7(2):T13. PubMed ID: 17342844
[No Abstract] [Full Text] [Related]
15. Syrrx acquisition signals maturation of structure-based discovery.
Ratner M
Nat Biotechnol; 2005 Apr; 23(4):400. PubMed ID: 15815651
[No Abstract] [Full Text] [Related]
16. New pharma-biotech company formation in India.
Saberwal G
Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124
[No Abstract] [Full Text] [Related]
17. Biopharmaceuticals in China.
Hu X; Ma Q; Zhang S
Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
[TBL] [Abstract][Full Text] [Related]
18. Protein expression -- CHI's Ninth Annual Conference -- optimizing protein expression.
Marchal-Gerez I
IDrugs; 2006 Mar; 9(3):174-6. PubMed ID: 16523379
[No Abstract] [Full Text] [Related]
19. The biotechnology industry: What's next?
Guertin PA
Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
[No Abstract] [Full Text] [Related]
20. Indian companies to watch in 2007.
Biotechnol J; 2007 Mar; 2(3):293. PubMed ID: 17354216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
